Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.

Perea S, López-Ribot JL, Wickes BL, Kirkpatrick WR, Dib OP, Bachmann SP, Keller SM, Martinez M, Patterson TF.

Antimicrob Agents Chemother. 2002 Jun;46(6):1695-703.

2.

Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV-infected patients.

Revankar SG, Sanche SE, Dib OP, Caceres M, Patterson TF.

AIDS. 1998 Dec 24;12(18):2511-3. No abstract available.

PMID:
9875598
3.

A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance.

Revankar SG, Kirkpatrick WR, McAtee RK, Dib OP, Fothergill AW, Redding SW, Rinaldi MG, Hilsenbeck SG, Patterson TF.

Am J Med. 1998 Jul;105(1):7-11.

PMID:
9688014
4.

Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients.

Revankar SG, Dib OP, Kirkpatrick WR, McAtee RK, Fothergill AW, Rinaldi MG, Redding SW, Patterson TF.

Clin Infect Dis. 1998 Apr;26(4):960-3.

PMID:
9564483
5.

Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients.

Revankar SG, Kirkpatrick WR, McAtee RK, Dib OP, Fothergill AW, Redding SW, Rinaldi MG, Patterson TF.

J Infect Dis. 1996 Oct;174(4):821-7.

PMID:
8843222

Supplemental Content

Support Center